Contract 75A50323F80027
Partner Therapeutics, Inc. · Department Of Health And Human Services · September 26, 2023
Partner Therapeutics, Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 26, 2023 for $60.20 million of work in pharmaceutical preparation manufacturing. Performance is in Lexington, MA. This is a task or delivery order issued under parent IDIQ 36F79723D0171. The contract has been modified 3 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 26, 2026. If all options are exercised, the contract could reach $99.32 million.
Contract details
- PIID
- 75A50323F80027
- Parent IDIQ
- 36F79723D0171
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Medical And Surgical Instruments, Equipment, And Supplies
- Place of performance
- Lexington, MA
- First action
- September 26, 2023
- Latest action
- March 26, 2026
Description
LEUKINE 250MCG QTY 14,635 AT THE UNIT PRICE OF $1,079.60
Modification timeline
-
March 26, 2026Mod P00006 · Exercise An Option$99.32M
-
September 8, 2025Mod P00005 · Other Administrative ActionLEUKINE 250MCG VIL INJ (5PKG)$83.52M
-
August 5, 2024Mod P00001 · Exercise An OptionLEUKINE 250MCG VIL INJ (5PKG)$44.40M
-
September 26, 2023Base awardLEUKINE 250MCG VIL INJ (5PKG)$22.20M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Seqirus USA Inc | Department Of Health And Human Services | March 27, 2026 | $2.02M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50323F80027?
Contract 75A50323F80027 is a federal contract awarded to Partner Therapeutics, Inc. by Department Of Health And Human Services on September 26, 2023 for $60.20 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 3 times since the base award.
Who won contract 75A50323F80027?
Partner Therapeutics, Inc. won contract 75A50323F80027 from Department Of Health And Human Services.
How much is contract 75A50323F80027 worth?
Contract 75A50323F80027 has obligated $60.20 million to date, with a total potential value of $99.32 million if all options are exercised.